Definitive Contract 75F40124C00097
- Not listed
- The U.S. Food and Drug Administration awarded a direct 8(a) sole source contract modification to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business headquartered in Ivins, Utah. The modification reduces the level of effort for Option Period 1 and exercises that option period through August 25, 2029. The contract, valued at approximately $896,500, is a time-and-materials definitive contract that provides subject matter expert and technical expert strategic planning services to...
- This is a direct 8(a) sole-source contract award from the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business based in Ivins, Utah. The 1-year base period contract, with two 1-year option periods, is for $752,623.09 and provides professional services support to the FDA's Center for Drug Evaluation and Research (CDER). The contract is a labor-hour, stand-alone agreement for services such as medical writing, scientific writing, editing,...
- The Food and Drug Administration (FDA) awarded a $9,594,482 labor hour contract to Kaiva Strategies, LLC, an 8(a) certified small business, to provide writer/editor support services to the Center for Drug Evaluation and Research (CDER) and Office of New Drugs (OND). The contract has an ultimate completion date of June 24, 2025 and was issued a notice to proceed on May 30. Kaiva Strategies is a tribally-owned, minority-owned small business based in Ivins, Utah that specializes in providing...
- The U.S. Food and Drug Administration (FDA) has awarded a single, labor-hour type contract to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business, for Preventive Control Support Services. The contract consists of a 12-month base period and four 12-month option periods, with a total ceiling value of $554,155.00. This contract was awarded as an 8(a) sole source set-aside. Kaiva Strategies, LLC is a small business that specializes in providing professional, administrative, and...
- The Food and Drug Administration (FDA) awarded a delivery order valued at $554,519.76 to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business headquartered in Ivins, Utah. This award is issued under the Professional, Administrative, and Consulting Services (PACS) Indefinite Delivery Indefinite Quantity (IDIQ) contract and is designated as a competitive 8(a) set-aside. The delivery order requires Kaiva Strategies to provide one full-time management analyst to support the...
- This is a 3-year, labor-hour type contract awarded by the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business, to provide technical support for the FDA's Office of Food Additive Safety (OFAS)/Division of Science and Technology. The contract is a direct 8(a) sole source award with a ceiling value of $653,425.94. Kaiva Strategies, LLC is a certified 8(a) Joint Venture and holds several other small business certifications, which have...
- This is a 1-year, labor-hour type contract awarded by the U.S. Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business. The contract is for $359,086.60 and provides regulatory support for the FDA's Generic Drug Program, including research and documentation to support the review of Abbreviated New Drug Applications. The contract is a direct 8(a) sole source award, leveraging Kaiva Strategies' 8(a) certification from the Small Business...
- This is a $470,227.14, firm fixed-price definitive contract awarded by the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business. The contract is to provide services to support the FDA's Center for Food Safety and Applied Nutrition (CFSAN) scientific messaging. The contract is an 8(a) sole source award with an ultimate completion date of August 21, 2028. Kaiva Strategies is a small business with multiple certifications, including 8(a)...
- The Food and Drug Administration (FDA) awarded a delivery order for scientific writing support to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business based in Ivins, Utah, on July 9, 2024. This labor-hour contract, valued at approximately $1.43 million with an ultimate completion date of July 31, 2025, will be performed in Silver Spring, Maryland. The award was made without a set-aside designation; however, Kaiva Strategies holds an SBA Certified 8(a) Joint Venture...
- This is a $753,422.88 sole source 8(a) contract awarded by the Food and Drug Administration (FDA) to Kaiva Strategies, LLC, a tribally-owned minority-owned small business. The contract is for administrative support services for the FDA's Office of the General Counsel. Kaiva Strategies is a certified 8(a) joint venture that holds multiple small business certifications, including HUBZone and small disadvantaged business status. The company has secured numerous prime contracts with the FDA and...
The Food and Drug Administration awarded a direct 8(a) sole source contract to Kaiva Strategies, LLC, a tribally-owned, minority-owned small business based in Ivins, Utah, on August 27, 2024. The contract is structured as a Time and Materials engagement with a ceiling value of approximately $3.1 million, consisting of one 12-month base period and four optional 12-month periods, with ultimate completion scheduled for April 25, 2029. The contract will be performed in Silver Spring, Maryland, and supports the FDA Office of Women's Health with professional services related to science-related activities. Kaiva Strategies holds current SBA 8(a) joint venture certification and maintains multiple small business designations including HUBZone, small disadvantaged business, and minority-owned business status. Kaiva Strategies specializes in providing professional, administrative, and consulting services to federal health agencies, with particular expertise in medical writing, scientific communication, regulatory support, and program management. The company has established a substantial track record with the FDA through multiple prime contract awards and two significant Indefinite Delivery Contracts valued at $100 million and $22 million respectively. Through these vehicles, Kaiva has delivered comprehensive support services across various FDA centers and offices, including the Center for Drug Evaluation and Research, Center for Devices and Radiological Health, and Center for Food Safety and Applied Nutrition. This direct 8(a) award reflects the contractor's demonstrated capability to support the FDA's critical public health mission through specialized professional services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Exercise an Option | $609.0k | 6/18/25 | |
| P00001 | Other Administrative Action | $0 | 9/4/24 | |
| Not listed | Not listed | $649.9k | 8/27/24 |